Literature DB >> 23890245

Nutraceuticals for canine liver disease: assessing the evidence.

Jean-Michel Vandeweerd1, Carole Cambier, Pascal Gustin.   

Abstract

Nutraceuticals, or nutritional supplements, have been promoted for the ancillary treatment of liver disease in dogs. However, minimal information is available in the scientific literature about commonly used nutraceuticals, such as S-adenosylmethionine, silymarin, and vitamin E. No strong clinical evidence exists regarding the efficacy of these compounds as hepatoprotectants in canine liver disease. Until this evidence exists, individual veterinarians must assume responsibility for their decision to use nutritional supplements in their canine patients with liver disease.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dietary supplement; Evidence; Liver; Nutraceuticals

Mesh:

Year:  2013        PMID: 23890245     DOI: 10.1016/j.cvsm.2013.05.003

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  2 in total

Review 1.  Evidences on Molecules Most Frequently Included in Canine and Feline Complementary Feed to Support Liver Function.

Authors:  Andrea Marchegiani; Alessandro Fruganti; Alessandra Gavazza; Sara Mangiaterra; Alessia Candellone; Eleonora Fusi; Giacomo Rossi; Matteo Cerquetella
Journal:  Vet Med Int       Date:  2020-05-09

2.  Mefepronic acid is associated with a decrease in serum liver enzyme activities in dogs with suspected hepatopathy.

Authors:  Fausto Quintavalla; Elisa Gelsi; Luca Battaglia; Raffaella Aldigeri; Roberto Ramoni
Journal:  Vet Med Sci       Date:  2021-05-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.